Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Sahin, Serdar; Haliloglu, Ozlem; Korkmaz, Ozge; DURCAN, Emre; Sahin, Humeyra; YUMUK, Volkan; DAMCI, Taner; Ilkova, Hasan; Siva, Zeynep

doi:10.3906/sag-2008-37

Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Sahin S., Haliloglu O., Korkmaz O. P., DURCAN E., Sahin H. R., YUMUK V. D., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.2, ss.735-742, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 51 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.3906/sag-2008-37
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.735-742
İstanbul Üniversitesi Adresli: Hayır

Özet

Background/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).